An internet-based survey of factors influencing patients’ satisfaction score and factors leading to discontinuation of treatment in lung cancer patients in China.

e18871Background: China instituted health insurance coverage in 2017 that covers targeted therapy drug gefitinib but not crizotinib. We analyzed factors that influence lung cancer patients' satisfa...